Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
NIPPON KAYAKU Firm on Acquisition of Pharmaceutical Manufacturing Business from Fuji Pharma
NIPPON KAYAKU <4272> traded firmly. After the close of trading on the 30th, the company announced it will acquire shares of a company that will succeed part of the pharmaceutical manufacturing business of Fuji Pharma (Omiya-ku, Saitama City). The company will take over the operations of the Toyama No. 2 Plant, which primarily engages in contract development and manufacturing of pharmaceutical products (injections). This acquisition aims to strengthen the stable supply system and expand production capacity for anticancer drugs and biosimilars.
Source: MINKABU PRESS
Related Articles
OMRON shares rise on planned sale of electronic components business to Carlyle
UACJ and Nippon Light Metal Rise on Aluminum Price Surge Following Iranian Attack on Refinery
Birdman Ranks 3rd in Rising Buy Predictions Among Individual Investors - Minkabu
TECHMATRIX rebounds on launch of Parasoft's C/C++test CT 2025.2
Tokyo FX Summary: Dollar Rises to Upper 159-Yen Range as Crude Oil Price Surge Spurs Dollar Buying
KADOKAWA Rebounds as Oasis Continues Share Accumulation, Raising Stake to 13.76%
Insource shares firm on contract win from Tokyo Metropolitan Government for educational material production
Stock in Focus: CTI Engineering Gains Traction on Takaichi Government's National Resilience Policy Theme
NAKAMURA CHOUKOU Rebounds on Commemorative Dividend Announcement, Shareholder Returns Appreciated
NITTO DENKO Gains on Share Buyback Plan of Up to 2.97% of Outstanding Shares